TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

RNS Number : 0500K

Alliance Pharma PLC

23 December 2015

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			ALLIANCE PHARMA PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights				X
Other (please specify):	Placing shares and exercise of broker's option			X
3. Full name of person(s) subject to the notification obligation:		MVM LIFE SCIENCE PARTNERS LLP
4. Full name of shareholder(s)  (if different from 3.):		PERSHING NOMINEES LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached:		17 December 2015
6. Date on which issuer notified:		17 December 2015
7. Threshold(s) that is/are crossed or reached:		11%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares GB0031030819

24,061,900

24,061,900

55,561,900

55,561,900

11.86%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

55,561,900

11.86%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
MVM Life Science Partners LLP is the fund manager for MVM Fund III LP (52,948,446 shares) and MVM Fund III (no2) LP (2,613,454 shares) held by the following nomineee: Pershing Nominees Limited 55,561,900 shares
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Figures are based on a total number of voting       rights of 468,179,146
14. Contact name:	Thomas Casdagli
15. Contact telephone number:	020 7557 7517

 

END

 

 

HOLFXLFLELFEFBK